Jpmorgan Chase & Co »

Sarepta Therapeutics Inc. cmn shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Sarepta Therapeutics Inc. cmn shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Sarepta Therapeutics Inc. cmn

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc. cmn held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc. cmn by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1M 55k 129.46
2023-12-31 $21M 217k 96.43
2023-09-30 $9.5M 78k 121.22
2023-06-30 $4.0M 35k 114.52
2023-03-31 $5.0M 36k 137.84
2022-12-31 $972k 7.5k 129.60
2022-03-31 $7.8M 100k 78.12
2021-12-31 $16M 174k 90.05
2020-12-31 $71M 418k 170.49
2020-09-30 $367k 2.6k 141.15
2019-12-31 $6.1M 48k 129.03
2019-06-30 $3.8M 30k 129.76
2019-03-31 $4.3M 36k 119.20
2018-12-31 $2.9M 27k 109.15
2018-09-30 $7.1M 44k 161.50
2018-06-30 $27M 202k 132.18

Top funds holding Sarepta Therapeutics Inc. cmn